PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab
Titel:
PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab
Auteur:
Jensen, J.D. Knoop, A. Laenkholm, A.V. Grauslund, M. Jensen, M.B. Santoni-Rugiu, E. Andersson, M. Ewertz, M.